Gurbuz, Y. Et Al. 2024. The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , vol.6, no.3 , 216-224.

Gurbuz, Y., Kocagul-Celikbas, A., Oztoprak, N., AYGEN, B., Batirel, A., Habiloglu, A. D., ... Aktug-Demir, N.(2024). The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , vol.6, no.3, 216-224.

Gurbuz, Yunus Et Al. "The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data," INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , vol.6, no.3, 216-224, 2024

Gurbuz, Yunus Et Al. "The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data." INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , vol.6, no.3, pp.216-224, 2024

Gurbuz, Y. Et Al. (2024) . "The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data." INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , vol.6, no.3, pp.216-224.

@article{article, author={Yunus Gurbuz Et Al. }, title={The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data}, journal={INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY}, year=2024, pages={216-224} }